Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Wacker Chemie AG: A reportable insider transaction was published on 13th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2024,
The Insider Transaction was made by Ohler, Dr Tobias . The transaction toke place on 10th May 2024. . The aggregated volume was 298.024,65 EUR, based on an average price of 100,65 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 13th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2024,
The Insider Transaction was made by Wörl, Angela . The transaction toke place on 10th May 2024. . The aggregated volume was 158.121,15 EUR, based on an average price of 100,65 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 13th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2024,
The Insider Transaction was made by Hartel, Dr Christian . The transaction toke place on 10th May 2024. . The aggregated volume was 396.158,40 EUR, based on an average price of 100,65 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 13th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2024,
The Insider Transaction was made by Kirsten, Dr Christian . The transaction toke place on 10th May 2024. . The aggregated volume was 212.975,40 EUR, based on an average price of 100,65 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 13th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2024,
The Insider Transaction was made by Ohler, Dr Tobias . The transaction toke place on 9th May 2024. The order was executed at the trading place Xetra. . The aggregated volume was 298.831,35 EUR, based on an average price of 100,65 EUR. The nature of the Investment was Sell.
Wacker Chemie AG: A reportable insider transaction was published on 19th May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2023,
The Insider Transaction was made by Ohler, Dr. Tobias . The transaction toke place on 19th May 2023. . The aggregated volume was 389.307,30 EUR, based on an average price of 127,10 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 19th May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2023,
The Insider Transaction was made by Wörl, Angela . The transaction toke place on 19th May 2023. . The aggregated volume was 210.731,80 EUR, based on an average price of 127,10 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 19th May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2023,
The Insider Transaction was made by Ohler, Dr. Tobias . The transaction toke place on 18th May 2023. The order was executed at the trading place Xetra. . The aggregated volume was 389.049,15 EUR, based on an average price of 127,02 EUR. The nature of the Investment was Sell.
Wacker Chemie AG: A reportable insider transaction was published on 19th May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2023,
The Insider Transaction was made by Hartel, Dr. Christian . The transaction toke place on 19th May 2023. . The aggregated volume was 513.865,30 EUR, based on an average price of 127,10 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 25th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 25th May 2022,
The Insider Transaction was made by Wörl, Angela . The transaction toke place on 24th May 2022. . The aggregated volume was 95.062,35 EUR, based on an average price of 160,85 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 25th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 25th May 2022,
The Insider Transaction was made by Willems, Auguste . The transaction toke place on 24th May 2022. . The aggregated volume was 299.020,15 EUR, based on an average price of 160,85 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 25th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 25th May 2022,
The Insider Transaction was made by Hartel, Dr. Christian . The transaction toke place on 24th May 2022. . The aggregated volume was 337.302,45 EUR, based on an average price of 160,85 EUR. The nature of the Investment was not specified.
Wacker Chemie AG: A reportable insider transaction was published on 25th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 25th May 2022,
The Insider Transaction was made by Ohler, Dr. Tobias . The transaction toke place on 24th May 2022. . The aggregated volume was 278.592,20 EUR, based on an average price of 160,85 EUR. The nature of the Investment was not specified.
Type | Total | Last | Made by | Go to |
---|---|---|---|---|
Equity Story | 27 | 15th March 2022 | EQS Group AG | EQS |
Corporate Research | 0 | - | - | Corporate Research |
Short Seller (DE) | 19 | 18th November 2024 | Qube Research & Technologies Limited | SSR (DE) |
Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.